All Stories

  1. Individual Profiling Across the Psychosis Continuum using Affinity Scores
  2. Subtle impairments of facial emotion expressions in individuals at ultra-high risk for psychosis
  3. Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: The Neuro-VR study
  4. Whole-brain functional connectivity predicts ultra-high risk for psychosis status and level of functioning
  5. Resting-state electroencephalography microstates in antipsychotic-naïve individuals across the psychosis spectrum
  6. Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study
  7. Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study
  8. Study protocol for a randomized clinical pilot trial investigating feasibility and efficacy of augmenting a virtual reality-assisted intervention targeting auditory verbal hallucinations with biofeedback: the Neuro-VR study
  9. Alleviating negative symptoms in schizophrenia using a Virtual Reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study
  10. Cognitive profiles across the psychosis continuum
  11. Publisher Correction: Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia
  12. Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia
  13. Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk
  14. Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis
  15. Brief rapport: Perceptual aberration in patients at ultra‐high risk for psychosis
  16. Associations between saliva alpha-amylase, heart rate variability, saliva cortisol and cognitive performance in individuals at ultra high-risk for psychosis
  17. Fibre density and fibre-bundle cross-section of the corticospinal tract are distinctly linked to psychosis-specific symptoms in antipsychotic-naïve patients with first-episode schizophrenia
  18. A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis
  19. Sleep disturbances and the association with attenuated psychotic symptoms in individuals at ultra high-risk of psychosis
  20. Premorbid functioning in adolescence associates with comorbid disorders in individuals at ultra‐high risk for psychosis: A brief report
  21. Normative modeling of brain morphometry in Clinical High-Risk for Psychosis
  22. White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis
  23. Premorbid adjustment associates with cognitive and functional deficits in individuals at ultra-high risk of psychosis
  24. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
  25. Cortico-cognition Coupling in Treatment Resistant Schizophrenia
  26. Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
  27. Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis
  28. Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra‐high risk for psychosis
  29. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis
  30. Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis
  31. Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning
  32. Effectiveness of cognitive remediation in the ultra‐high risk state for psychosis
  33. No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
  34. Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial
  35. Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition
  36. Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states
  37. The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends
  38. Predictors of remission from the ultra‐high risk state for psychosis
  39. Assessing social skills in individuals at ultra-high risk for psychosis: Validation of the High Risk Social Challenge task (HiSoC)
  40. Investigating Cognitive and Clinical Predictors of Real-Life Functioning, Functional Capacity, and Quality of Life in Individuals at Ultra-High Risk for Psychosis
  41. Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
  42. Development of Executive Functions as Reflected in Daily Life Behaviors in Young Adults at Ultra-High Risk for Psychosis: Associations With Symptoms and Functioning
  43. Basic symptoms influence real‐life functioning and symptoms in individuals at high risk for psychosis
  44. Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra‐high risk for psychosis
  45. Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis
  46. Non-pharmacological modulation of cerebral white matter organization: A systematic review of non-psychiatric and psychiatric studies
  47. T16. GLUTAMATERGIC CHANGES IN UHR
  48. Examining speed of processing of facial emotion recognition in individuals at ultra-high risk for psychosis: Associations with symptoms and cognition
  49. The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review
  50. Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis
  51. Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?